Barclays Initiates Coverage On Medtronic with Equal-Weight Rating, Announces Price Target of $95
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsInitiationPrice TargetHot
Barclays analyst Christopher Pasquale initiates coverage on Medtronic (NYSE:MDT) with a Equal-Weight rating and announces Price Target of $95.
Barclays analyst Christopher Pasquale initiates coverage on Medtronic (NYSE:MDT) with a Equal-Weight rating and announces Price Target of $95.